3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stroke
2
Prostatic Neoplasms
2
Osteoporosis
2
Neoplasms
2
Kidney Diseases
2
Hypertension
2
Heart Failure
2
Frailty
2
Diabetes Mellitus
2
Colorectal Neoplasms
2
Cardiovascular Diseases
2
Arthritis
2
Weight Loss
1
Rectal Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Neoplasm Metastasis
1
Motor Activity
1
Lung Neoplasms
1
Digestive System Carcinoma
1
Colonic Neoplasms
1
Chronic Disease
1
Bone Diseases, Metabolic
1
Interventions
Everolimus
16
Octreotide
6
pembrolizumab
5
lanreotide
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
lenvatinib
3
arginyllysine
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
pasireotide
2
lutetium Lu 177 dotatate
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Temozolomide
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors
×
Nutrition Assessment
×
Clear all
No trials found.